3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Left Ventricular Systolic Dysfunction: new trials by email Literature Review of Left Ventricular Systolic Dysfunction trials Research Report on Left Ventricular Systolic Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ertugliflozin for Functional Mitral Regurgitation Ertugliflozin, Placebo - Mitral Valve Insufficiency, Left Ventricular Systolic Dysfunction | Phase 3 | Completed | Asan Medical Center | 128 | 2020-11-04 | 2025-01-06 |
| Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion Placebos, Dobutamine - Sepsis, Cardiomyopathies | Phase 3 | Completed | University Hospital, Limoges | 136 | 2020-09-20 | 2025-11-21 |
| Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry Linagliptin, Placebo - Diabetes Mellitus, Type 2, Left Ventricular Systolic Dysfunction | Phase 3 | Completed | Heart Care Foundation | 188 | 2015-07-01 | 2021-05-25 |
Ventricular Dysfunction, Left (3) · Cardiomyopathies (1) · Diabetes Mellitus, Type 2 (1) · Mitral Valve Insufficiency (1) · Sepsis (1)
Cardiovascular Diseases (3) · Heart Diseases (3) · Ventricular Dysfunction (3) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Heart Valve Diseases (1) · Infections (1) · Inflammation (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Systemic Inflammatory Response Syndrome (1)
Dobutamine (1) · Linagliptin (1) · ertugliflozin (1)
Asan Medical Center (1) · Heart Care Foundation (1) · University Hospital, Limoges (1)
France (1) · Italy (1) · South Korea (1)